PCM
EOLS icon

Prelude Capital Management’s Evolus EOLS Stock Holding History

Prelude Capital Management’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,000
Closed -$12K – 1576
2019
Q4 		$12K Hold
1,000
– – ﹤0.01% 1677
2019
Q3 		$16K Buy
+1,000
New +$16.4K ﹤0.01% 1424

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Prelude Capital Management's EOLS Position: Q2 2026 in Review

Prelude Capital Management reduced its Evolus (EOLS) stake by 0.07% in Q2 2026, selling an estimated $213 and leaving 51,267 shares worth $356K. The position accounts for 0.03% of the portfolio, ranked #676.

Prelude Capital Management first reported a position in EOLS in Q1 2020 and has held it in 7 quarters since. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Prelude Capital Management held 51,267 shares of Evolus worth $356K as of Q2 2026.
  • Prelude Capital Management sold 36 Evolus shares in Q2 2026, an estimated $213.
  • Evolus made up 0.03% of Prelude Capital Management's portfolio in Q2 2026, its #676 holding.
  • Prelude Capital Management first reported a position in Evolus in Q1 2020 and has held it in 7 quarters since.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.